CoChat

Depressive and anxiety disorders in concert–A synthesis of findings on comorbidity in the NESDA study

Open access
ter Meulen, Wendela G., Draisma, Stasja, van Hemert, Albert M., Schoevers, Robert A., Kupka, Ralph W., Beekman, Aartjan T.F., Penninx, Brenda W.J.H. · 2021 · Journal of Affective Disorders
Cited by 170

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Comorbidity of depressive and anxiety disorders is common and remains incompletely comprehended. This paper summarizes findings from the Netherlands Study of Depression and Anxiety (NESDA) regarding prevalence, temporal sequence, course and longitudinal patterns; sociodemographic, vulnerability and neurobiological indicators; and functional, somatic and mental health indicators of comorbidity. METHODS: Narrative synthesis of earlier NESDA based papers on comorbidity (n=76). RESULTS: Comorbidity was the rule in over three-quarter of subjects with depressive and/or anxiety disorders, most often preceded by an anxiety disorder. Higher severity and chronicity characterized a poorer comorbidity course. Over time, transitions between depressive and anxiety disorders were common. Consistent comorbidity risk indicators in subjects with depressive and anxiety disorders were childhood trauma, neuroticism and early age of onset. Psychological vulnerabilities, such as trait avoidance tendencies, were more pronounced in comorbid than in single disorders. In general, there were few differences in biological markers and neuroimaging findings between persons with comorbid versus single disorders. Most functional, somatic, and other mental health indicators, ranging from disability to cardiovascular and psychiatric multimorbidity, were highest in comorbid disorders. LIMITATIONS: The observational design of NESDA limits causal inference. Attrition was higher in comorbid relative to single disorders. CONCLUSIONS: As compared to single disorders, persons with comorbid depressive and anxiety disorders were characterized by more psychosocial risk determinants, more somatic and other psychiatric morbidities, more functional impairments, and poorer outcome. These results justify specific attention for comorbidity of depressive and anxiety disorders, particularly in treatment settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2021.02.004

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 86

  1. Batelaan, 2014, Two-year course trajectories of anxiety disorders: do DSM classifications matter?, J. Clin. Psychiatry, 10.4088/JCP.13m08837 · DOI · Paper page
  2. Beekman, 2012, Stagering en profilering van psychiatrische stoornissen [Staging and profiling of psychiatric disorders]., Tijdschr. Psychiatr., 54, 915
  3. Benjamin, 2013, Anxiety and related outcomes in young adults 7 to 19 years after receiving treatment for child anxiety, J. Consult. Clin. Psychol., 10.1037/a0033048 · DOI · Paper page
  4. Bijl, 2000, Psychiatric morbidity, service use, and need for care in the general population: results of the Netherlands Mental Health Survey and incidence study, Am. J. Public Health.
  5. Black, 2017, Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort, Psychol. Med., 10.1017/S0033291716002828 · DOI · Paper page
  6. Black, 2018, Uric acid in major depressive and anxiety disorders, J. Affect. Disord., 10.1016/j.jad.2017.09.003 · DOI
  7. Bokma, 2020, A clinical staging approach to improving diagnostics in anxiety disorders: is it the way to go?, Aust. N. Z. J. Psychiatry., 10.1177/0004867419887804 · DOI
  8. Boschloo, 2011, Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands study of depression and anxiety (NESDA), J. Affect. Disord., 10.1016/j.jad.2010.12.014 · DOI · Paper page
  9. Boschloo, 2013, Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the netherlands study of depression and anxiety (nesda), J. Clin. Psychiatry., 10.4088/JCP.12m08159 · DOI · Paper page
  10. Broekhof, 2015, Long-lasting effects of affective disorders and childhood trauma on dispositional optimism, J. Affect. Disord., 10.1016/j.jad.2015.01.022 · DOI
  11. Bron, 2016, Prevalence of ADHD symptoms across clinical stages of major depressive disorder, J. Affect. Disord., 197, 29, 10.1016/j.jad.2016.02.053 · DOI
  12. Bus, 2015, Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time, Mol. Psychiatry, 10.1038/mp.2014.83 · DOI · Paper page
  13. Chinn, 2000, A simple method for converting an odds ratio to effect size for use in meta-analysis, Stat. Med., 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M · DOI · Paper page
  14. Conway, 2018, Evaluating dimensional models of psychopathology in outpatients diagnosed with emotional disorders: a cautionary tale, Depress. Anxiety, 10.1002/da.22740 · DOI
  15. De Bles, 2019, Trait anger and anger attacks in relation to depressive and anxiety disorders, J. Affect. Disord., 10.1016/j.jad.2019.08.023 · DOI
  16. De Graaf, 2002, Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study, Am. J. Psychiatry, 10.1176/appi.ajp.159.4.620 · DOI · Paper page
  17. De Graaf, 2003, Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - findings from the Netherlands Mental Health Survey and Incidence Study, Soc. Psychiatry Psychiatr. Epidemiol., 10.1007/s00127-003-0597-4 · DOI · Paper page
  18. De Wit, 2011, Are sedentary television watching and computer use behaviors associated with anxiety and depressive disorders?, Psychiatry Res., 10.1016/j.psychres.2010.07.003 · DOI
  19. De Wit, 2010, Depressive and anxiety disorders and the association with obesity, physical, and social activities, Depress. Anxiety, 10.1002/da.20738 · DOI · Paper page
  20. De Wit, 2015, Depressive and anxiety disorders: associated with losing or gaining weight over 2 years?, Psychiatry Res., 10.1016/j.psychres.2015.02.025 · DOI
  21. Difrancesco, 2019, Sleep, circadian rhythm, and physical activity patterns in depressive and anxiety disorders: a 2-week ambulatory assessment study, Depress. Anxiety., 10.1002/da.22949 · DOI · Paper page
  22. Distel, 2016, Borderline personality features in depressed or anxious patients, Psychiatry Res., 10.1016/j.psychres.2016.05.007 · DOI
  23. Eikelenboom, 2019, A 6-year longitudinal study of predictors for suicide attempts in major depressive disorder, Psychol. Med., 10.1017/S0033291718001423 · DOI · Paper page
  24. Eikelenboom, 2012, Do depression and anxiety converge or diverge in their association with suicidality?, J. Psychiatr. Res., 10.1016/j.jpsychires.2012.01.025 · DOI
  25. Fava, 2000, Anxiety disorders in major depression, Compr. Psychiatry., 10.1016/S0010-440X(00)90140-8 · DOI · Paper page
  26. Ferentinos, 2015, Familiality and SNP heritability of age at onset and episodicity in major depressive disorder, Psychol. Med., 10.1017/S0033291715000215 · DOI
  27. Fichter, 2010, Twenty-five-year course and outcome in anxiety and depression in the upper bavarian longitudinal community study, Acta Psychiatr. Scand., 10.1111/j.1600-0447.2009.01512.x · DOI · Paper page
  28. Garber, 2016, Treatment and prevention of depression and anxiety in youth: test of cross-over effects, Depress. Anxiety, 10.1002/da.22519 · DOI · Paper page
  29. Generaal, 2014, Basal inflammation and innate immune response in chronic multisite musculoskeletal pain, Pain, 10.1016/j.pain.2014.05.007 · DOI
  30. Gerrits, 2012, Impact of pain on the course of depressive and anxiety disorders, Pain, 10.1016/j.pain.2011.11.001 · DOI · Paper page
  31. Gerritsen, 2019, Long-term glucocorticoid levels measured in hair in patients with depressive and anxiety disorders, Psychoneuroendocrinology, 10.1016/j.psyneuen.2018.11.019 · DOI · Paper page
  32. Gibson-Smith, 2016, Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the netherlands study of depression and anxiety, J. Clin. Psychiatry, 10.4088/JCP.14m09658 · DOI
  33. Gorman, 1996, Comorbid depression and anxiety spectrum disorders, Depress. Anxiety, 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J · DOI · Paper page
  34. Grecucci, 2013, Reappraising social emotions: the role of inferior frontal gyrus, temporo-parietal junction and insula in interpersonal emotion regulation, Front. Hum. Neurosci., 10.3389/fnhum.2013.00523 · DOI · Paper page
  35. Groen, 2020, Comorbidity between depression and anxiety: Assessing the role of bridge mental states in dynamic psychological networks, BMC Med., 10.1186/s12916-020-01738-z · DOI · Paper page
  36. Hendriks, 2015, Long-term work disability and absenteeism in anxiety and depressive disorders, J. Affect. Disord., 10.1016/j.jad.2015.03.004 · DOI
  37. Hofmeijer-Sevink, 2018, Presence and predictive value of obsessive-compulsive symptoms in anxiety and depressive disorders, Can. J. Psychiatry, 10.1177/0706743717711170 · DOI
  38. Hovens, 2017, Emotional scars: impact of childhood trauma on the development of depressive and anxiety disorders later in life, Tijdschr. Psychiatr.
  39. Hovens, 2010, Childhood life events and childhood trauma in adult patients with depressive, anxiety and comorbid disorders vs. controls, Acta Psychiatr. Scand., 10.1111/j.1600-0447.2009.01491.x · DOI · Paper page
  40. Iancu, 2020, Long-term disability in major depressive disorder: a 6-year follow-up study, Psychol. Med., 10.1017/S0033291719001612 · DOI
  41. Judd, 2013, Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course, JAMA Psychiatry, 10.1001/jamapsychiatry.2013.1957 · DOI · Paper page
  42. Kendler, 2019, From many to one to many - the search for causes of psychiatric illness, JAMA Psychiatry, 10.1001/jamapsychiatry.2019.1200 · DOI · Paper page
  43. Kendler, 2007, The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample, Psychol. Med., 10.1017/S0033291706009135 · DOI · Paper page
  44. Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey, Arch. Gen. Psychiatry, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  45. Kleiman, 2012, Cognitive vulnerability to comorbidity: looming cognitive style and depressive cognitive style as synergistic predictors of anxiety and depression symptoms, J. Behav. Ther. Exp. Psychiatry, 10.1016/j.jbtep.2012.05.008 · DOI
  46. Kok, 2017, The impact of conscientiousness, mastery, and work circumstances on subsequent absenteeism in employees with and without affective disorders, BMC Psychol., 10.1186/s40359-017-0179-y · DOI
  47. Lamers, 2011, One-year severity of depressive symptoms: results from the NESDA study, Psychiatry Res., 10.1016/j.psychres.2011.07.005 · DOI
  48. Lamers, 2012, Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA), Compr. Psychiatry, 53, 63, 10.1016/j.comppsych.2011.01.011 · DOI · Paper page
  49. Lamers, 2019, Longitudinal association between depression and inflammatory markers: results from the Netherlands study of depression and anxiety, Biol. Psychiatry, 10.1016/j.biopsych.2018.12.020 · DOI · Paper page
  50. Lammerts, 2016, Longitudinal associations between biopsychosocial factors and sustainable return to work of sick-listed workers with a depressive or anxiety disorder, J. Occup. Rehabil., 10.1007/s10926-015-9588-z · DOI
  51. Licht, 2012, Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study, Neuropsychopharmacology, 10.1038/npp.2012.107 · DOI
  52. Ligthart, 2013, Anxiety and depression are associated with migraine and pain in general: an investigation of the interrelationships, J. Pain, 10.1016/j.jpain.2012.12.006 · DOI
  53. Lyketsos, 1994, The life chart interview: a standardized method to describe the course of psychopathology, Int. J. Methods Psychiatr. Res.
  54. Maes, 2018, Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses, Neurotox. Res., 10.1007/s12640-018-9906-2 · DOI
  55. Merikangas, 1995, Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies, Eur. Arch. Psychiatry Clin. Neurosci., 10.1007/BF02190407 · DOI · Paper page
  56. Milaneschi, 2014, The association between low vitamin D and depressive disorders, Mol. Psychiatry, 10.1038/mp.2013.36 · DOI · Paper page
  57. Monroy-Jaramillo, 2018, Telomere length in psychiatric disorders: is it more than an ageing marker?, World J. Biol. Psychiatry, 10.1080/15622975.2016.1273550 · DOI
  58. Norberg, 2008, Quality of life and anxiety and depressive disorder comorbidity, J. Anxiety Disord., 10.1016/j.janxdis.2008.03.005 · DOI
  59. Pannekoek, 2015, Investigating distinct and common abnormalities of resting-state functional connectivity in depression, anxiety, and their comorbid states, Eur. Neuropsychopharmacol., 10.1016/j.euroneuro.2015.08.002 · DOI
  60. Penninx, 2008, The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods, Int. J. Methods Psychiatr. Res., 17, 121, 10.1002/mpr.256 · DOI · Paper page
  61. Plaisier, 2010, Work functioning in persons with depressive and anxiety disorders: the role of specific psychopathological characteristics, J. Affect. Disord., 10.1016/j.jad.2010.01.072 · DOI
  62. Richards, 2011, Prevalence and clinical course of depression: a review, Clin. Psychol. Rev., 10.1016/j.cpr.2011.07.004 · DOI · Paper page
  63. Schoevers, 2003, Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study, Int. J. Geriatr. Psychiatry, 10.1002/gps.1001 · DOI · Paper page
  64. Schoevers, 2008, Managing the patient with co-morbid depression and an anxiety disorder, Drugs, 10.2165/00003495-200868120-00002 · DOI
  65. Seldenrijk, 2015, Depression, anxiety and 6-year risk of cardiovascular disease, J. Psychosom. Res., 10.1016/j.jpsychores.2014.10.007 · DOI
  66. Shah, 2020, Transdiagnostic clinical staging in youth mental health: a first international consensus statement, World Psychiatry, 10.1002/wps.20745 · DOI · Paper page
  67. Spinhoven, 2015, Anxious or depressed and still happy?, PLoS One, 10.1371/journal.pone.0139912 · DOI
  68. Struijs, 2017, Approach and avoidance tendencies in depression and anxiety disorders, Psychiatry Res., 10.1016/j.psychres.2017.07.010 · DOI
  69. Ten Have, 2017, Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population, Acta Psychiatr. Scand., 10.1111/acps.12753 · DOI · Paper page
  70. Thesing, 2018, Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders, Psychoneuroendocrinology, 10.1016/j.psyneuen.2017.10.005 · DOI
  71. Van Eeden, 2019, Neuroticism and chronicity as predictors of 9-year course of individual depressive symptoms, J. Affect. Disord., 10.1016/j.jad.2019.04.052 · DOI
  72. Van Milligen, 2011, Objective physical functioning in patients with depressive and/or anxiety disorders, J. Affect. Disord., 10.1016/j.jad.2010.12.005 · DOI
  73. Van Reedt Dortland, 2010, Associations between serum lipids and major depressive disorder: results from the Netherlands study of depression and anxiety (NESDA), J. Clin. Psychiatry, 10.4088/JCP.08m04865blu · DOI · Paper page
  74. Van Tol, 2011, Functional MRI correlates of visuospatial planning in out-patient depression and anxiety, Acta Psychiatr. Scand., 10.1111/j.1600-0447.2011.01702.x · DOI · Paper page
  75. Van Tuijl, 2018, Self-esteem instability in current, remitted, recovered, and comorbid depression and anxiety, Cognit. Ther. Res., 10.1007/s10608-018-9926-5 · DOI
  76. Van Tuijl, 2016, Implicit and explicit self-esteem in current, remitted, recovered, and comorbid depression and anxiety disorders: the NESDA study, PLoS One, 10.1371/journal.pone.0166116 · DOI
  77. Verduijn, 2017, Using clinical characteristics to identify which patients with major depressive disorder have a higher genetic load for three psychiatric disorders, Biol. Psychiatry, 10.1016/j.biopsych.2016.05.024 · DOI · Paper page
  78. Verhoeven, 2015, Anxiety disorders and accelerated cellular ageing, Br. J. Psychiatry, 10.1192/bjp.bp.114.151027 · DOI · Paper page
  79. Verhoeven, 2014, Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study, Mol. Psychiatry, 19, 895, 10.1038/mp.2013.151 · DOI · Paper page
  80. Vogelzangs, 2016, Cytokine production capacity in depression and anxiety, Transl. Psychiatry, 10.1038/tp.2016.92 · DOI · Paper page
  81. Vogelzangs, 2010, Cardiovascular disease in persons with depressive and anxiety disorders, J. Affect. Disord., 10.1016/j.jad.2010.02.112 · DOI · Paper page
  82. Wang, 2007, Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative, World Psychiatry
  83. Wittchen, 1994, Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review, J. Psychiatr. Res., 28, 57, 10.1016/0022-3956(94)90036-1 · DOI · Paper page
  84. Wray, 2018, Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression, Nat. Genet., 10.1038/s41588-018-0090-3 · DOI · Paper page
  85. Yoon, 2012, Stress reactivity in social anxiety disorder with and without comorbid depression, J. Abnorm. Psychol., 10.1037/a0025079 · DOI · Paper page
  86. Young, 2004, Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression, Biol. Psychiatry, 10.1016/j.biopsych.2004.03.017 · DOI · Paper page

Cited by

See all 170

Metadata

Authors
ter Meulen, W. G., Draisma, S., van Hemert, A. M., Schoevers, R. A., Kupka, R. W., Beekman, A. T. F., & Penninx, B. W. J. H.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2021-04
Volume
284
Pages
85-97
ISSN
0165-0327 (ISSN-L)
OpenAlex
W3127424424
Cited by
170
References
56
FWCI
18.34
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
ZonMw

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.